MEDX ETF holdings (NASDAQ) | MetaTrader

Vollständige Grafik anzeigen Full chart

Übersicht Alle Anlagen Heatmap

Top-Positionen Market Value Shares Weight %

LLY Eli Lilly & Co 2.83 M 3 077.00 15.59%

US BANK MMDA - USBGFS 7 1.82 M 1.82 M 10.03%

ABBV AbbVie Inc 1.53 M 7 034.00 8.43%

NVS Novartis AG 1.34 M 8 791.00 7.40%

JNJ Johnson & Johnson 1.08 M 4 401.00 5.93%

A

AZN AstraZeneca PLC 1.04 M 5 256.00 5.71%

BMY Bristol-Myers Squibb Co 930.86 K 15.35 K 5.13%

IONS Ionis Pharmaceuticals Inc 858.13 K 11.43 K 4.73%

AMGN Amgen Inc 760.35 K 2 161.00 4.19%

ALNY Alnylam Pharmaceuticals Inc 751.74 K 2 272.00 4.14%

ALKS Alkermes PLC 746.06 K 21.10 K 4.11%

MRK Merck & Co Inc 740.26 K 6 154.00 4.08%

PFE Pfizer Inc 666.51 K 23.74 K 3.67%

GSK GSK PLC 569.51 K 10.32 K 3.14%

BIIB Biogen Inc 523.77 K 2 857.00 2.89%

REGN Regeneron Pharmaceuticals Inc 509.94 K 660.00 2.81%

CRSP CRISPR Therapeutics AG 460.05 K 9 671.00 2.53%

BEAM Beam Therapeutics Inc 209.49 K 8 791.00 1.15%

NTLA Intellia Therapeutics Inc 169.07 K 13.19 K 0.93%

VNDA Vanda Pharmaceuticals Inc 164.02 K 23.74 K 0.90%

1
2

Nachrichten

Medmix FY25 revenue falls, dividend cut 80%; shares down 17%

Medmix Geschäftsjahr 2025: Marge steigt um 90 Basispunkte bei 7,4 % Umsatzrückgang

Medmix FY 2025 slides: margins surge 90bps as revenue falls 7.4%

Medmix: Margenwachstum trotz Umsatzrückgang im zweiten Halbjahr 2025

Earnings call transcript: Medmix sees margin growth amid revenue dip in H2 2025

Medical ETF (MEDX) Touches New 52-Week High

Stifel nimmt Medmix mit „Buy“ in die Bewertung auf – Kursziel 14,50 CHF

Stifel initiates coverage on Medmix stock with Buy rating, CHF14.50 target

Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in

Horizon Kinetics Q3 2025 Commentary (HKHC)

ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data